KADER THIAM

Company: GenOway

Job title: Senior Vice President - Discovery Preclinical Models & Services

Seminars:

Precise and Translational Preclinical Models for Assessment of Immune- Targeting Agents 4:30 pm

Outlining BRGSF-HIS mice: immunodeficient mice displaying functional human lymphoid and myeloid compartments, without side effects Assessing efficacy and toxicity induced by immune checkpoint inhibitors, cell engagers and combo therapies in BRGSF-HIS mice, which displays a wide therapeutic window Showcase of assessment of immune targeting agents in immune checkpoint humanized modelsRead more

day: Day One PM